138 related articles for article (PubMed ID: 10355836)
21. Residual mass after treatment of primary cervical lymphoma: the utility of gallium 67 and MRI.
Kasales CJ; Langer JE; Young CT; Singapuri K; Arger PH
Abdom Imaging; 1994; 19(3):274-7. PubMed ID: 8019363
[TBL] [Abstract][Full Text] [Related]
22. Positive gallium-67 citrate scintigraphy in Wiskott-Aldrich syndrome with malignant lymphoma.
Sandrock D; Lastoria S; Merino MJ; Neumann RD
Eur J Nucl Med; 1991; 18(11):928-30. PubMed ID: 1752263
[TBL] [Abstract][Full Text] [Related]
23. Gallium-67 scintigraphy in the management: Hodgkin's disease and non-Hodgkin's lymphoma.
Rehm PK
Cancer Biother Radiopharm; 1999 Aug; 14(4):251-62. PubMed ID: 10850311
[TBL] [Abstract][Full Text] [Related]
24. Residual mass and negative gallium scintigraphy in treated lymphoma: when is the gallium scan really negative?
Kaplan WD
J Nucl Med; 1990 Mar; 31(3):369-71. PubMed ID: 2308009
[No Abstract] [Full Text] [Related]
25. Orbital lymphoma versus reactive lymphoid hyperplasia: an analysis of the use of computed tomography in differential diagnosis.
Westacott S; Garner A; Moseley IF; Wright JE
Br J Ophthalmol; 1991 Dec; 75(12):722-5. PubMed ID: 1768660
[TBL] [Abstract][Full Text] [Related]
26. Follicular lymphoma transforming into diffuse large B-cell lymphoma in spleen: Simultaneous appearance of both on
Makis W; Ciarallo A; Petrogiannis-Haliotis T; Rosenberg A; Probst S
Clin Imaging; 2017; 43():88-92. PubMed ID: 28259031
[TBL] [Abstract][Full Text] [Related]
27. B-cell immunoblastic sarcoma as a cause of a photopenic lesion on bone scintigraphy: an initial description.
Hung GL; Chen DC; Siegel ME; Ansari AN; Raval JK; Colletti PM
Radiat Med; 1989; 7(4):186-8. PubMed ID: 2608919
[TBL] [Abstract][Full Text] [Related]
28. Correlation of flow cytometric parameters and transferrin receptors with gallium-67 scintigraphic images in lymphoma patients.
Kiratli PO; Canpinar H; Ruacan S; Kansu E
Nucl Med Commun; 2000 Oct; 21(10):925-31. PubMed ID: 11130333
[TBL] [Abstract][Full Text] [Related]
29. Lymphoma: predictive value of Ga-67 scintigraphy after treatment.
Front D; Ben-Haim S; Israel O; Epelbaum R; Haim N; Even-Sapir E; Kolodny GM; Robinson E
Radiology; 1992 Feb; 182(2):359-63. PubMed ID: 1732950
[TBL] [Abstract][Full Text] [Related]
30. [The role of gallium-67 citrate scintigraphy in gastro-intestinal malignant lymphoma].
Kataoka M; Tsuda T; Kawamura M; Itoh H; Komatsu A; Mogami H; Tanada S; Iio A; Hamamoto K
Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Feb; 50(2):155-63. PubMed ID: 2362795
[TBL] [Abstract][Full Text] [Related]
31. Positron emission tomography changes management, improves prognostic stratification and is superior to gallium scintigraphy in patients with low-grade lymphoma: results of a multicentre prospective study.
Scott AM; Gunawardana DH; Wong J; Kirkwood I; Hicks RJ; Ho Shon I; Ramshaw JE; Robins P
Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):347-53. PubMed ID: 18931840
[TBL] [Abstract][Full Text] [Related]
32. Comparison of technetium-99m tetrofosmin and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
Yang CC; Sun SS; Lin CC; Kao CH; Lee CC
Anticancer Res; 2001; 21(5):3695-8. PubMed ID: 11848545
[TBL] [Abstract][Full Text] [Related]
33. Comparison of (18)F Flurodeoxyglucose PET with Ga-67 scintigraphy and conventional imaging modalities in pediatric lymphoma.
Mody RJ; Bui C; Hutchinson RJ; Frey KA; Shulkin BL
Leuk Lymphoma; 2007 Apr; 48(4):699-707. PubMed ID: 17454627
[TBL] [Abstract][Full Text] [Related]
34. High-dose gallium imaging in lymphoma.
Anderson KC; Leonard RC; Canellos GP; Skarin AT; Kaplan WD
Am J Med; 1983 Aug; 75(2):327-31. PubMed ID: 6881185
[TBL] [Abstract][Full Text] [Related]
35. Value of low-dose gallium-67 imaging in detection of non-Hodgkin's lymphoma recurrence.
Nakayama M; Sakahara H; Minowa Y; Sasai K; Ishigaki T; Saga T; Nakamoto Y; Yao Z; Hiraoka M; Sakai K; Konishi J
Radiat Med; 1997; 15(2):79-83. PubMed ID: 9192431
[TBL] [Abstract][Full Text] [Related]
36. Gallium-67 scintigraphy in well-differentiated lymphocytic lymphoma of the skin.
Beck RN; Blumhardt R; Bennett W; Cable H; McCauley R; Telepak RJ; Pacheco J; Phillips L
Clin Nucl Med; 1985 Aug; 10(8):589-91. PubMed ID: 3862493
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic potential of intravenous 67-gallium in non-Hodgkin's lymphoma.
Huijgens PC; Jonkhoff AR; Hoekstra OS; Ossenkoppele GJ; Teule GJ
Eur J Haematol; 1993 Oct; 51(4):206-8. PubMed ID: 8243608
[TBL] [Abstract][Full Text] [Related]
38. Orbital lymphoma associated with acquired immune deficiency syndrome (AIDS).
Reifler DM; Warzynski MJ; Blount WR; Graham DM; Mills KA
Surv Ophthalmol; 1994; 38(4):371-80. PubMed ID: 8160110
[TBL] [Abstract][Full Text] [Related]
39. 67Ga scintigraphy for the evaluation of recurrences and residual masses in patients with lymphoma.
Setoain FJ; Pons F; Herranz R; Vidal-Sicart S; Lomeña F; Ayuso C; Montserrat E; Setoain J
Nucl Med Commun; 1997 May; 18(5):405-11. PubMed ID: 9194081
[TBL] [Abstract][Full Text] [Related]
40. Massive Pelvic Lymphadenopathy Due to Recurrent Non-Hodgkin Lymphoma Incidentally Revealed on a 99mTc-MDP Bone Scintigraphy.
Huang J; Xie P
Clin Nucl Med; 2016 Jun; 41(6):502-3. PubMed ID: 26828142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
